Send us a text

Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recent systematic review and meta-analysis that looks at continuing versus withholding RAS inhibitors before noncardiac surgery. Here we go!

1. Evaluating the risks and benefits of continuing versus withholding renin–angiotensin system inhibitors: a systematic review and meta-analysis with trial sequential analysis (0:00 – 8:20).

The Good Stuff (8:21 – 9:44):

• NotebookLM

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods